U.S., June 11 -- An application to own the trademark for 'NAVSUNLI' has been filed on Nov. 01, 2024.
Owner(s):
REGENXBIO Inc.; 9804 Medical Center Drive, , MARYLAND
Goods and/or Services:
For: Biological preparations for medical use in the treatment of genetic diseases and disorders, and central nervous system (CNS) disorders, namely, neurodegenerative disorders; pharmaceutical preparations, namely, recombinant adeno-associated viral (rAAV) vectors for use in gene therapy; Pharmaceutical preparations for the treatment of genetic diseases and disorders and central nervous system (CNS) disorders, namely, neurodegenerative disorders; Pharmaceutical preparations for use in gene therapy; Clinical medical reagents for use in gene therapy; Pha...